EUVIMEDEUVIMED entdecken
Übersichtsarbeit

TGF-β Receptors and Signalling Mechanisms

J L Wrana

Mineral and Electrolyte Metabolism · 1998

DOI: 10.1159/000057359 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Mineral and Electrolyte Metabolism, 1998. Verfasst von J L Wrana. Beteiligte Einrichtung: The Hospital for Sick Children and Department of Medical Genetics and Microbiology, University of Toronto, Ont, Canada. Hauptthemen laut MEDLINE: Signal Transduction. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transforming growth factor-β (TGF-β) is the founding member of a large superfamily of related growth and differentiation factors that include bone morphogenetic proteins and activins. TGF-β signals through two related transmembrane ser/thr kinase receptors, the type I and type II receptors. Signalling is initiated when the ligand binds to the type II receptor which is followed by recruitment of the type I receptor into a heteromeric complex. Within the complex the type II receptor transphosphorylates and activates the type I receptor kinase which targets downstream signalling components of the pathway. Proteins related to the Drosophila gene Mothers against dpp (MAD) are critical downstream substrates of the type I kinase. The vertebrate members of the MAD-related family, termed Smad 2 and Smad3, interact specifically with the TGF-β type I receptor and are phosphorylated on the last two serines of a conserved C-terminal SSXS motif. This phosphorylation induces association between these receptor-regulated Smads and Smad4 followed by translocation of the heteromeric complex to the nucleus. In the nucleus, heteromeric complexes of Smads can interact with DNA and with specific DNA binding transcription factors to elicit gene responses to TGF-β. Thus TGF-β signalling involves a direct pathway from the cell surface receptors to the nucleus. Recently, a novel mechanism to negatively regulate TGF-β signalling was described that involves another class of MADR proteins. These anti-MADR proteins potently inhibit TGF-β signalling by functioning as direct antagonists of the TGF-β receptor type I kinase domain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionAnimalsCell NucleusGenes, Tumor SuppressorHumansInsect ProteinsMacromolecular SubstancesNeoplasmsReceptors, Transforming Growth Factor betaTrans-ActivatorsTransforming Growth Factor beta

Substanzen

Insect ProteinsMacromolecular SubstancesReceptors, Transforming Growth Factor betaTrans-ActivatorsTransforming Growth Factor beta

Autor:innen und Institutionen

  • The Hospital for Sick Children and Department of Medical Genetics and Microbiology, University of Toronto, Ont, Canada.

Zitieren

APA

Wrana, J. L. (1998). TGF-β Receptors and Signalling Mechanisms. Mineral and Electrolyte Metabolism. https://doi.org/10.1159/000057359

Vancouver

Wrana JL. TGF-β Receptors and Signalling Mechanisms. Mineral and Electrolyte Metabolism. 1998. doi:10.1159/000057359

BibTeX
@article{Wrana1998,
  author = {Wrana, J L},
  title = {TGF-β Receptors and Signalling Mechanisms},
  journal = {Mineral and Electrolyte Metabolism},
  year = {1998},
  doi = {10.1159/000057359}
}
Kostenlos starten →